Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of established osteoporosis.

Literature DB >> 9491820

Management of established osteoporosis.

R M Francis¹.

Abstract

Entities: Disease

Mesh：

Substances：
Anabolic Agents
Hormones

Year: 1998 PMID： 9491820 PMCID： PMC1873362 DOI： 10.1046/j.1365-2125.1998.00665.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

47 in total

1. Pathogenesis of vertebral crush fractures in men.

Authors: S P Baillie; C E Davison; F J Johnson; R M Francis
Journal: Age Ageing Date: 1992-03 Impact factor: 10.668

2. The effect of postmenopausal estrogen therapy on bone density in elderly women.

Authors: D T Felson; Y Zhang; M T Hannan; D P Kiel; P W Wilson; J J Anderson
Journal: N Engl J Med Date: 1993-10-14 Impact factor: 91.245

3. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.

Authors: R R Love; R B Mazess; H S Barden; S Epstein; P A Newcomb; V C Jordan; P P Carbone; D L DeMets
Journal: N Engl J Med Date: 1992-03-26 Impact factor: 91.245

4. Vitamin D3 and calcium to prevent hip fractures in elderly women.

Authors: M C Chapuy; M E Arlot; F Duboeuf; J Brun; B Crouzet; S Arnaud; P D Delmas; P J Meunier
Journal: N Engl J Med Date: 1992-12-03 Impact factor: 91.245

5. Treatment of postmenopausal osteoporosis with transdermal estrogen.

Authors: E G Lufkin; H W Wahner; W M O'Fallon; S F Hodgson; M A Kotowicz; A W Lane; H L Judd; R H Caplan; B L Riggs
Journal: Ann Intern Med Date: 1992-07-01 Impact factor: 25.391

6. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

Authors: S T Harris; N B Watts; R D Jackson; H K Genant; R D Wasnich; P Ross; P D Miller; A A Licata; C H Chesnut
Journal: Am J Med Date: 1993-12 Impact factor: 4.965

7. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

Authors: K Overgaard; M A Hansen; S B Jensen; C Christiansen
Journal: BMJ Date: 1992-09-05

Review 5. Osteoporosis.

Authors: S P Tuck; R M Francis
Journal: Postgrad Med J Date: 2002-09 Impact factor: 2.401

5 in total

Management of established osteoporosis.

1. Pathogenesis of vertebral crush fractures in men.

2. The effect of postmenopausal estrogen therapy on bone density in elderly women.

3. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.

4. Vitamin D3 and calcium to prevent hip fractures in elderly women.

5. Treatment of postmenopausal osteoporosis with transdermal estrogen.

6. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

7. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

8. Annual injection of vitamin D and fractures of aged bones.

9. Effect of calcium supplementation on bone loss in postmenopausal women.

10. Axial and appendicular bone density predict fractures in older women.

1. Mining MEDLINE for the treatment of osteoporosis.

Review 2. Alendronate: an update of its use in osteoporosis.

Review 3. Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.

Review 4. Raloxifene: a review of its use in postmenopausal osteoporosis.

Review 5. Osteoporosis.